From 13 to 15 November 2012, the World Trade Center, Moscow, will host the XVI Russian Cancer Congress featuring expositions of the largest pharmaceutical and biotechnology companies in the Russian cancer market. The event will be attended by Skolkovo Biomedical...
Osteros Biomedica, Ltd, formed in September 2012 for the development and commercialization of drugs for the treatment of cancer-induced bone disease became the ninth "Maxwell Biotech Group" portfolio company listed as resident of the Biomed Cluster...
In early September the investment committee of Maxwell Biotech Venture Fund (“MBVF”), founded with the participation of the Russian Government’s RVC, approved the binding terms and the amount of an investment in a newly established private...